Toll Free: 1-888-928-9744
Published: Dec, 2015 | Pages:
24 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Vaxil Bio Therapeutics Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Vaxil Bio Therapeutics Ltd. - Product Pipeline Review - 2015', provides an overview of the Vaxil Bio Therapeutics Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxil Bio Therapeutics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Vaxil Bio Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Vaxil Bio Therapeutics Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Vaxil Bio Therapeutics Ltd.'s pipeline products Reasons To Buy - Evaluate Vaxil Bio Therapeutics Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Vaxil Bio Therapeutics Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Vaxil Bio Therapeutics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Vaxil Bio Therapeutics Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vaxil Bio Therapeutics Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Vaxil Bio Therapeutics Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Vaxil Bio Therapeutics Ltd. Snapshot 4 Vaxil Bio Therapeutics Ltd. Overview 4 Key Information 4 Key Facts 4 Vaxil Bio Therapeutics Ltd. - Research and Development Overview 5 Key Therapeutic Areas 5 Vaxil Bio Therapeutics Ltd. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Vaxil Bio Therapeutics Ltd. - Pipeline Products Glance 9 Vaxil Bio Therapeutics Ltd. - Clinical Stage Pipeline Products 9 Phase I Products/Combination Treatment Modalities 9 Vaxil Bio Therapeutics Ltd. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Vaxil Bio Therapeutics Ltd. - Drug Profiles 11 ImMucin 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 MTbuVax 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 SPMAb-2.1 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 SPMAb-6 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Vaxil Bio Therapeutics Ltd. - Pipeline Analysis 16 Vaxil Bio Therapeutics Ltd. - Pipeline Products by Target 16 Vaxil Bio Therapeutics Ltd. - Pipeline Products by Route of Administration 17 Vaxil Bio Therapeutics Ltd. - Pipeline Products by Molecule Type 18 Vaxil Bio Therapeutics Ltd. - Recent Pipeline Updates 19 Vaxil Bio Therapeutics Ltd. - Dormant Projects 21 Vaxil Bio Therapeutics Ltd. - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 23 Disclaimer 24
List of Tables
Vaxil Bio Therapeutics Ltd., Key Information 4 Vaxil Bio Therapeutics Ltd., Key Facts 4 Vaxil Bio Therapeutics Ltd. - Pipeline by Indication, 2015 6 Vaxil Bio Therapeutics Ltd. - Pipeline by Stage of Development, 2015 7 Vaxil Bio Therapeutics Ltd. - Monotherapy Products in Pipeline, 2015 8 Vaxil Bio Therapeutics Ltd. - Phase I, 2015 9 Vaxil Bio Therapeutics Ltd. - Preclinical, 2015 10 Vaxil Bio Therapeutics Ltd. - Pipeline by Target, 2015 16 Vaxil Bio Therapeutics Ltd. - Pipeline by Route of Administration, 2015 17 Vaxil Bio Therapeutics Ltd. - Pipeline by Molecule Type, 2015 18 Vaxil Bio Therapeutics Ltd. - Recent Pipeline Updates, 2015 19 Vaxil Bio Therapeutics Ltd. - Dormant Developmental Projects,2015 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.